Deep Vein Thrombosis despite Receiving Anticoagulant Prophylaxis; a Cross-sectional Study

Message:
Abstract:
Introduction
Contradicting statistics exist regarding the prevalence of deep vein thrombosis (DVT) following lower limb trauma despite administration of anti-thrombotic agents. The present study aimed to evaluate the prevalence of DVT in patients with lower limb trauma despite receiving anticoagulant prophylaxis.
Methods
The present crosssectional study was carried out to evaluate the prevalence of traumatic lower limbs DVT despite anti-thrombotic therapy, in patients presenting to emergency department. Patients over 18 years old with traumas in the areas lower than knees in need for fixation with cast or splint for > 2 weeks were enrolled. Data were analyzed using SPSS version 21 and descriptive statistics.
Results
130 patients with the mean age of 40.05 ± 18.5 (15-92) were studied (61.5% male). 18 (13.8%) cases had history of drug abuse, 1 (0.8%) had diabetes mellitus, 8 (6.2%) had hypertension, 1 (0.8%) had asthma, and 1 (0.8%) had history of cranial vascular thrombosis. Mechanism of trauma was falling down in 44 (33.8%) cases, road traffic collisions in 50 (38.5%), and direct trauma in 36 (27.7%). 3 (2.3%) patients developed DVT despite receiving prophylactic anti-thrombotic agents. The mean time interval between discharge and development of DVT was 6 ± 3.6 days.
Conclusion
Based on the results of the present study, the prevalence of DVT, despite receiving anti-thrombotic agents, in patients with lower limb trauma in need for fixation for > 2 weeks was 2.3%. All three cases of DVT in this study were developed in the first 2 weeks of fixation.
Language:
Persian
Published:
Iranian Journal of Emergency medicine, Volume:3 Issue: 3, 2016
Pages:
98 to 102
magiran.com/p1594497  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!